ZYBT1, a potent, irreversible Bruton's Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancer.
Ghoshdastidar K, Patel H, Bhayani H, Patel A, Thakkar K, Patel D, Sharma M, Singh J, Mohapatra J, Chatterjee A, Patel D, Bahekar R, Sharma R, Gupta L, Patel N, Giri P, Srinivas NR, Jain M, Bandyopadhyay D, Patel PR, Desai RC.
Ghoshdastidar K, et al. Among authors: mohapatra j.
Pharmacol Res Perspect. 2020 Aug;8(4):e00565. doi: 10.1002/prp2.565.
Pharmacol Res Perspect. 2020.
PMID: 32790160
Free PMC article.